Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Packaging
What you should do
- Verify whether your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Other Recent Recalls
Dantrium Intravenous (Dantrolene sodium for injection)
Dantrium Intravenous (Dantrolene sodium for injection): Presence of particulate matter
Type I2026-10-19
Highest health risk
Aleve
Aleve 200 mg caplets: Recalled from wholesalers (Distribution Error)
Type III2026-10-15
Low health risk
Claritin Allergy Tablets
Claritin Allergy Tablets 10 mg: Recalled from wholesalers (Distribution Error)
Type III2026-10-15
Low health risk
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.